Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boutagy

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1974
Cardenolide analogs. V. Cardiotonic activity of semisynthetic analogs of digitoxigeninR Thomas, J Boutagy, A Gelbart
Journal of Pharmaceutical Sciences|November 1, 1974
Synthesis and biological activity of semisynthetic digitalis analogsR Thomas, J Boutagy, A Gelbart
Journal of Chromatography|February 24, 1989
Determination of isradipine and the oxidative pyridine metabolite in human plasma by high-performance liquid chromatographyJ Boutagy, F Rumble, F Dunagan
British Journal of Clinical Pharmacology|October 1, 1986
The effect of glucose on acetylation statusD Suhardjono, J Boutagy, G M Shenfield
British Journal of Cancer|August 1, 1994
Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemiaP Galettis, J Boutagy, D D Ma
Clinical Pharmacology and Therapeutics|October 1, 1985
Interactions between ethanol and oral contraceptive steroidsJ Hobbes, J Boutagy, G M Shenfield
British Journal of Clinical Pharmacology|May 1, 1986
Debrisoquine oxidation in an Australian populationG F Peart, J Boutagy, G M Shenfield
Journal of Medicinal Chemistry|October 1, 1982
Cardenolide analogues. 14. Synthesis and biological activity of glucosides of C17 beta-modified derivatives of digitoxigeninP Smith, L Brown, J Boutagy, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotypeG F Peart, J Boutagy, G M Shenfield
Circulation Research|June 1, 1980
The digitalis receptor. Inferences from structure-activity relationship studiesR Thomas, L Brown, J Boutagy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1974
Cardenolide analogs. V. Cardiotonic activity of semisynthetic analogs of digitoxigeninR Thomas, J Boutagy, A Gelbart
Journal of Pharmaceutical Sciences|November 1, 1974
Synthesis and biological activity of semisynthetic digitalis analogsR Thomas, J Boutagy, A Gelbart
Journal of Chromatography|February 24, 1989
Determination of isradipine and the oxidative pyridine metabolite in human plasma by high-performance liquid chromatographyJ Boutagy, F Rumble, F Dunagan
British Journal of Clinical Pharmacology|October 1, 1986
The effect of glucose on acetylation statusD Suhardjono, J Boutagy, G M Shenfield
British Journal of Cancer|August 1, 1994
Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemiaP Galettis, J Boutagy, D D Ma
Clinical Pharmacology and Therapeutics|October 1, 1985
Interactions between ethanol and oral contraceptive steroidsJ Hobbes, J Boutagy, G M Shenfield
British Journal of Clinical Pharmacology|May 1, 1986
Debrisoquine oxidation in an Australian populationG F Peart, J Boutagy, G M Shenfield
Journal of Medicinal Chemistry|October 1, 1982
Cardenolide analogues. 14. Synthesis and biological activity of glucosides of C17 beta-modified derivatives of digitoxigeninP Smith, L Brown, J Boutagy, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotypeG F Peart, J Boutagy, G M Shenfield
Circulation Research|June 1, 1980
The digitalis receptor. Inferences from structure-activity relationship studiesR Thomas, L Brown, J Boutagy, et al.
Pageof 4